Olivia Kersey, Patient Engagement Strategist, outlines what we can learn from 2021 to optimise patient engagement strategy and implementation in 2022.
While there would be no such thing as the pharmaceutical industry without patients, it’s only in recent years that collaboration with patients has started to enter the mainstream. While 2021 was a good year for patient engagement, 2022 can be both bigger and better.
The Prime Patient team are proud to have had a poster accepted for presentation at the 2022 European meeting of ISMPP (International Society for Medical Publication Professionals), held virtually on 25-26 January. The poster, one of five accepted across Prime Global, presents the results of an internal survey that aimed to identify barriers and solutions to working with patient authors in medical publications.
Prime Global, a recognised global leader in medical communications and market access, has strengthened its Evidence, Access, and Patient Practice with the acquisition of HCD Economics, an academically aligned organisation focusing on health economics and outcomes research (HEOR) and real-world evidence (RWE). HCD will work closely with Prime Global’s highly experienced medical communications agencies and specialist consultancies, including market access consultancy, Prime Access, and patient engagement experts, Prime Patient, to deliver integrated evidence-led services.
What’s next for different disciplines of patient engagement in 2022? Find out more with Emma Sutcliffe, Jon Hoggard,Olivia K, and Ross Jackson. We are committed to providing Voice to Value practices that are egalitarian and enduring.
It is hard to overstate the importance of social media in today’s healthcare ecosystem. Research has shown us that 74% of all internet users engage with social media, with a huge 80% of those people looking for health-related information or engaging with health-related topics.1 Social media has also become a place for people with chronic conditions to connect with each other, with research suggesting 40% of patients rely on social media to assess how others are dealing with and managing their condition.2
Promoted by Reuters as ‘The only destination for North American patient centricity leaders’, Pharma & Patient USA 2021 was a 3-day virtual event that took place in November 2021 with a mission to ‘Embed lived experience across the value chain to surpass centricity and embrace ground-breaking integration’. Prime Global’s VP Patient Recruitment Services, Ross Jackson, was in attendance and shares his insights from the event.
This World AIDS Day, Emma Sutcliffe, SVP Patient Insights and Solutions, takes a look at how far we’ve come and how far we’ve yet to go. Patient activism is a key factor in this progression; Emma discusses her experiences over a near-three-decade career in medical communications and working with patient organisations and how central the patient really is.
In recognition of Lung Cancer Awareness Month, Olivia Kersey, Patient Engagement Strategist, illustrates current opportunities for the pharmaceutical industry to better meet lung cancer patients’ needs across clinical trials and beyond.
Patient involvement in clinical trial design has evolved to provide opportunity for patients to be involved in medical publications. This evolution has allowed medical publications to gain invaluable patient perspectives on clinical research, by involving patients as authors in the development of plain language summaries and other, more traditional types of research publications1.
Kirsty Anderson, Digital Project Lead, took the time to discuss all things digital with us! In this interview, she shares insight into her role, the challenges and opportunities of a digital project, and her views on the future of digital.
We were glad to attend the ISMPP West 2021 Meeting on October 21–22, the first in-person meeting in almost two years! The meeting focused on opportunities for connectivity, transparency, and inclusivity, and Jenny Blackham, VP Client Partnerships, gave us first-hand insight! Read below to learn more about the key themes at the conference.
Because so many people see Facebook ads, you can expect at least a few negative or other problematic comments. Even though you do not author such comments, viewers will associate them with your study. Ross Jackson, VP Patient Recruitment Services, discusses how to handle such comments.
To mark Breast Cancer Awareness Month, we picked the brains of two of our experts! Farai Muldoon, Client Services Director, and Kiran Nandra, Scientific Team Lead, draw on their experience to give insight into how medical communications plays a role in breast cancer.
Is Facebook the most effective means of reaching a wide audience when it comes to patient recruitment strategy? Ross Jackson, VP Patient Recruitment Services, shares his thoughts with The Huxley Morton podcast in a new video. He is, literally, the man who wrote the book on patient recruitment for clinical trials using Facebook ads! Listen to the podcast below.
Emma Sutcliffe, SVP, Patient Insight and Solutions gives an overview of patient engagement, benefits of investing in patient engagement programmes and why elevating patient engagement should be an essential business spend for patient safety, support and societal gain.
Our experts, Sue O’Leary, Senior Vice President Prime Access, Jenny Blackham, Vice President Client Partnerships and Head of Digital Solutions Michelle Collins recently led a webinar with the team at NetworkPharmaand MedComms Networking. Discussing ‘the digital payer – fact or fiction?’ the webinar was a brilliant platform to discuss perspectives and share ideas about about evolving payer communications in the changing digital landscape.
The World Health Organisation defines health literacy as ‘the personal characteristics and social resources needed for individuals and communities to access, understand, appraise and use information and services to make decisions about health.’1 Where levels of health literacy are high, people are able to play an active role in improving and maintaining their own health, engage successfully with community action for health, and push governments to meet their responsibilities in addressing health and health equity.2
We’re looking back at the insightful ISMPP Annual 2021 conference, ‘Medical Communications 2.0: Creating and Embracing Opportunities in a Time of Transformation’. Our experts collected summaries from their favourite sessions! Click below to read. read more >>
On Wednesday 1st September 2021, we launched the first-ever annual Patient Engagement Day – and what a day it was! Olivia Kersey, Patient Strategist, takes a look at some of the highlights.
Starting as a spontaneous brainwave from Emma Sutcliffe, our SVP, Patient Insights and Solutions, Patient Engagement Day 2021 involved a webinar with top industry thought leaders, video collaboration with three of our Patient Partners, a Twitter campaign, case study sharing, and the development of a toolkit to help other organisations to get involved. And that was just for the launch!
Plain language summaries, or PLS, are a concept that has indelibly changed our world of medical publications, likely forever. And yet, we still seem a world away from having PLS integrated fully and consistently into publications practices. In fact, it has taken several years of head-scratching to even align on a definition for PLS for publications, versus patient lay summaries of clinical trials, layperson summaries, and so on.
View the on-demand recording of our Patient Engagement Day webinar on ‘Amplifying the Patient Voice in Healthcare’. Emma Sutcliffe and panellists, Shona Davies and Laura McKeaveney discuss what it really takes to amplify the patient voice in healthcare.
The WHO Global Patient Safety Action Plan 2021-2030 is a key document that outlines the changes and aspirations that the WHO has for the next decade around protection and wellbeing of patients. The plan, produced on 3 August 2021, aims to educate various stakeholders (NHS, HCPs, pharma and patient groups) about current issues surrounding patient safety and outline their proposed solutions1. The main goal over the next 10 years is a ‘zero harm philosophy’1. This means that although it’s impossible to totally wipe out errors in patient safety, the goal is to work towards being as close to zero harm as possible. But why are we telling you about it now? Because it’s World Patient Safety Day!
Once considered science fiction, a number of different gene therapy approaches are now being adopted in clinical practice to target a range of diseases. Our Prime Omics team discuss ‘overcoming the challenges of gene therapy’ in their whitepaper. Read the full piece below. read more >>
We’re delighted with the success of our first annual Patient Engagement Day, held on 1 September 2021. The day was a real opportunity for partners in the patient engagement space to join conversations, support best practices and drive new ideas and innovation that help to bridge that gap between pharma and patients. read more >>
Pre 2019, physical medical conferences and exhibitions were an established, entrenched habit of our industry. This single point of focus was the axis of our traditional annual engagement model until COVID-19 hit our shores in early 2020. Michelle Collins, Head of Digital Solutions, discusses. read more >>
Find out all about the Studio at Prime Global in this interview with Tris Miles, our Global Studio Director! Tris reveals his career experiences and gives us insight into the central hub of delivery and creativity of our communications.